{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T23:37:09Z","timestamp":1789256229178,"version":"build-2803163510"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.crad.2025.106952","type":"journal-article","created":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T19:21:11Z","timestamp":1746904871000},"page":"106952","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Elucidating the biological function of computed tomography (CT)-based radiomics biomarkers in serous ovarian cancer"],"prefix":"10.1016","volume":"86","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-8586-3437","authenticated-orcid":false,"given":"M.","family":"Kishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4617-1377","authenticated-orcid":false,"given":"I.","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Tomono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Nishibuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Murakami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2025.106952_bib1","unstructured":"World cancer research Fund. https:\/\/wwwwcrforg\/n.d."},{"key":"10.1016\/j.crad.2025.106952_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/jjco\/hyq167","article-title":"Population-based survival of cancer patients diagnosed between 1993 and 1999 in Japan: a chronological and international comparative study","volume":"41","author":"Matsuda","year":"2011","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.crad.2025.106952_bib3","series-title":"Monitoring of cancer incidence in Japan - survival 2009-2011 report","year":"2020"},{"key":"10.1016\/j.crad.2025.106952_bib4","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.crad.2025.106952_bib5","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2013.51.4489","article-title":"Bevacizumab combined with chemotherapy for platinum-resistant recurrent ovarian cancer: the AURELIA open-label randomized phase III trial","volume":"32","author":"Pujade-Lauraine","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.crad.2025.106952_bib6","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1810858","article-title":"Maintenance olaparib in patients with newly diagnosed advanced ovarian cancer","volume":"379","author":"Moore","year":"2018","journal-title":"New Engl J Med"},{"key":"10.1016\/j.crad.2025.106952_bib7","article-title":"Olaparib tablets as maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer and a BRCA1\/2 mutation (SOLO2\/ENGOT-Ov21): a final analysis of a double-blind, randomised, placebo-controlled, phase 3 trial","volume":"22","author":"Psoveda","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.crad.2025.106952_bib8","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1911361","article-title":"Olaparib plus bevacizumab as first-line maintenance in ovarian cancer","volume":"381","author":"Ray-Coquard","year":"2019","journal-title":"New Engl J Med"},{"key":"10.1016\/j.crad.2025.106952_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.mri.2012.06.010","article-title":"Radiomics: the process and the challenges","volume":"30","author":"Kumar","year":"2012","journal-title":"Magn Reson Imaging"},{"key":"10.1016\/j.crad.2025.106952_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.crad.2022.01.038","article-title":"Development of a radiomic\u2013clinical nomogram for prediction of survival in patients with serous ovarian cancer","volume":"77","author":"Hong","year":"2022","journal-title":"Clin Radiol"},{"key":"10.1016\/j.crad.2025.106952_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2021.110018","article-title":"A CT-based radiomics nomogram for predicting early recurrence in patients with high-grade serous ovarian cancer","volume":"145","author":"Chen","year":"2021","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.crad.2025.106952_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.610742","article-title":"Preoperative prediction of metastasis for ovarian cancer based on computed tomography radiomics features and clinical factors","volume":"11","author":"Ai","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.106952_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-018-5389-z","article-title":"Radiomics of high-grade serous ovarian cancer: association between quantitative CT features, residual tumour and disease progression within 12 months","volume":"28","author":"Rizzo","year":"2018","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.106952_bib14","first-page":"77","article-title":"Radiomics and radiogenomics: extracting more information from medical images for the diagnosis and prognostic prediction of ovarian cancer","volume":"11","author":"Zeng","year":"2024","journal-title":"Mil Med Res"},{"key":"10.1016\/j.crad.2025.106952_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101536","article-title":"CT radiomics combined with clinical variables for predicting the overall survival of hepatocellular carcinoma patients after hepatectomy","volume":"26","author":"Liu","year":"2022","journal-title":"Transl Oncol"},{"key":"10.1016\/j.crad.2025.106952_bib16","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-018-5770-y","article-title":"Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients","volume":"29","author":"Yang","year":"2019","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.106952_bib17","article-title":"Radiomics analysis of PET and CT components of 18F-FDG PET\/CT imaging for prediction of progression-free survival in advanced high-grade serous ovarian cancer","volume":"11","author":"Wang","year":"2021","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.106952_bib18","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.2021202553","article-title":"The biological meaning of radiomic features","volume":"298","author":"Tomaszewski","year":"2021","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2025.106952_bib19","doi-asserted-by":"crossref","DOI":"10.1007\/s00261-018-1840-5","article-title":"Association between CT-texture-derived tumor heterogeneity, outcomes, and BRCA mutation status in patients with high-grade serous ovarian cancer","volume":"44","author":"Meier","year":"2019","journal-title":"Abdom Radiol"},{"key":"10.1016\/j.crad.2025.106952_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2024.1477759","article-title":"CT-based radiomics predicts HRD score and HRD status in patients with ovarian cancer","volume":"14","author":"Wu","year":"2025","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.106952_bib21","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1186\/s12957-021-02440-x","article-title":"Screening of CXC chemokines in the microenvironment of ovarian cancer and the biological function of CXCL10","volume":"19","author":"Li","year":"2021","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.crad.2025.106952_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.678747","article-title":"Identification of CXCL10-relevant tumor microenvironment characterization and clinical outcome in ovarian cancer","volume":"12","author":"Jin","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/j.crad.2025.106952_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/bjc.2013.673","article-title":"Granulocyte colony-stimulating factor receptor signalling via Janus kinase 2\/signal transducer and activator of transcription 3 in ovarian cancer","volume":"110","author":"Kumar","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/j.crad.2025.106952_bib24","article-title":"Radiomics signatures based on computed tomography for noninvasive prediction of CXCL10 expression and prognosis in ovarian cancer","volume":"7","author":"Wang","year":"2024","journal-title":"Cancer Rep (Hoboken)"},{"key":"10.1016\/j.crad.2025.106952_bib25","article-title":"Contrast-enhanced computed tomography radiomics predicts colony-stimulating factor 3 expression and clinical prognosis in ovarian cancer","author":"Lv","year":"2024","journal-title":"Acad Radiol"},{"key":"10.1016\/j.crad.2025.106952_bib26","series-title":"The cancer Genome Atlas ovarian cancer collection (TCGA-OV) (Version 4) [Data set]. The Cancer Imaging Archive","author":"Holback","year":"2016"},{"key":"10.1016\/j.crad.2025.106952_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2017.124","article-title":"The public cancer radiology imaging collections of the Cancer Imaging Archive","volume":"4","author":"Prior","year":"2017","journal-title":"Sci Data"},{"key":"10.1016\/j.crad.2025.106952_bib28","series-title":"Enhancing gene set overrepresentation analysis with large language models","author":"Zhu","year":"2024"},{"key":"10.1016\/j.crad.2025.106952_bib29","series-title":"Network-based pathway enrichment analysis. 2013 IEEE international conference on bioinformatics and biomedicine","first-page":"218","author":"Liu","year":"2013"},{"key":"10.1016\/j.crad.2025.106952_bib30","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13244-023-01415-8","article-title":"CheckList for EvaluAtion of Radiomics research (CLEAR): a step-by-step reporting guideline for authors and reviewers endorsed by ESR and EuSoMII","volume":"14","author":"Kocak","year":"2023","journal-title":"Insights Imaging"},{"key":"10.1016\/j.crad.2025.106952_bib31","article-title":"Seeing beyond the tumor: computed tomography image-based radiomic analysis helps identify ovarian clear cell carcinoma subtype in epithelial ovarian cancer","volume":"128","author":"Ren","year":"2023","journal-title":"Radiologia Med"},{"key":"10.1016\/j.crad.2025.106952_bib32","doi-asserted-by":"crossref","DOI":"10.1177\/02841851231188915","article-title":"CT-based radiomics nomogram analysis for assessing BRCA mutation status in patients with high-grade serous ovarian cancer","volume":"64","author":"Cao","year":"2023","journal-title":"Acta Radiol"},{"key":"10.1016\/j.crad.2025.106952_bib33","article-title":"Multi-region radiomic analysis based on multi-sequence MRI can preoperatively predict microvascular invasion in hepatocellular carcinoma","volume":"12","author":"Gao","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.crad.2025.106952_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95643-x","article-title":"Prediction of radiation pneumonitis after definitive radiotherapy for locally advanced non-small cell lung cancer using multi-region radiomics analysis","volume":"11","author":"Kawahara","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.crad.2025.106952_bib35","doi-asserted-by":"crossref","DOI":"10.1007\/s00330-023-09709-7","article-title":"Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC","volume":"33","author":"Fan","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.crad.2025.106952_bib36","article-title":"RIP1 promotes proliferation through G2\/M checkpoint progression and mediates cisplatin-induced apoptosis and necroptosis in human ovarian cancer cells","volume":"41","author":"lian","year":"2020","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.crad.2025.106952_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2006.10.061","article-title":"Weakened spindle checkpoint with reduced BubR1 expression in paclitaxel-resistant ovarian carcinoma cell line SKOV3-TR30","volume":"105","author":"Fu","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.crad.2025.106952_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/path.2452","article-title":"E2Fs mediate a fundamental cell-cycle deregulation in high-grade serous ovarian carcinomas","volume":"217","author":"De Meyer","year":"2009","journal-title":"J Pathol"},{"key":"10.1016\/j.crad.2025.106952_bib39","article-title":"A novel biomarker, MRPS12 functions as a potential oncogene in ovarian cancer and is a promising prognostic candidate","volume":"100","author":"Qiu","year":"2021","journal-title":"Medicine (United States)"},{"key":"10.1016\/j.crad.2025.106952_bib40","doi-asserted-by":"crossref","DOI":"10.7150\/thno.33444","article-title":"Multi-omics profiling reveals key signaling pathways in ovarian cancer controlled by STAT3","volume":"9","author":"Lu","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.crad.2025.106952_bib41","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1158\/1078-0432.CCR-21-3208","article-title":"PET-based radiogenomics supports mTOR pathway targeting for hepatocellular carcinoma","volume":"28","author":"An","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.crad.2025.106952_bib42","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.12688\/f1000research.141148.1","article-title":"Impact of slice thickness on reproducibility of CT radiomic features of lung tumors","volume":"12","author":"Gupta","year":"2023","journal-title":"F1000Res"},{"key":"10.1016\/j.crad.2025.106952_bib43","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/RLI.0000000000000180","article-title":"Measuring computed tomography scanner variability of radiomics features","volume":"50","author":"Mackin","year":"2015","journal-title":"Invest Radiol"},{"key":"10.1016\/j.crad.2025.106952_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0256152","article-title":"Radiomics machine learning study with a small sample size: single random training-test set split may lead to unreliable results","volume":"16","author":"An","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.crad.2025.106952_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0124165","article-title":"False discovery rates in PET and CT studies with texture features: a systematic review","volume":"10","author":"Chalkidou","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.crad.2025.106952_bib46","doi-asserted-by":"crossref","DOI":"10.1186\/s40644-020-00311-4","article-title":"How to develop a meaningful radiomic signature for clinical use in oncologic patients","volume":"20","author":"Papanikolaou","year":"2020","journal-title":"Cancer Imaging"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926025001576?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926025001576?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:14:15Z","timestamp":1762114455000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926025001576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":46,"alternative-id":["S0009926025001576"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2025.106952","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidating the biological function of computed tomography (CT)-based radiomics biomarkers in serous ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2025.106952","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"106952"}}